1. Home
  2. HALO vs TX Comparison

HALO vs TX Comparison

Compare HALO & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • TX
  • Stock Information
  • Founded
  • HALO 1998
  • TX 1961
  • Country
  • HALO United States
  • TX Luxembourg
  • Employees
  • HALO N/A
  • TX N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • TX Steel/Iron Ore
  • Sector
  • HALO Health Care
  • TX Industrials
  • Exchange
  • HALO Nasdaq
  • TX Nasdaq
  • Market Cap
  • HALO 7.6B
  • TX 6.2B
  • IPO Year
  • HALO N/A
  • TX 2006
  • Fundamental
  • Price
  • HALO $71.82
  • TX $33.10
  • Analyst Decision
  • HALO Buy
  • TX Hold
  • Analyst Count
  • HALO 8
  • TX 5
  • Target Price
  • HALO $70.25
  • TX $34.40
  • AVG Volume (30 Days)
  • HALO 2.2M
  • TX 247.7K
  • Earning Date
  • HALO 08-05-2025
  • TX 07-29-2025
  • Dividend Yield
  • HALO N/A
  • TX 8.11%
  • EPS Growth
  • HALO 68.93
  • TX N/A
  • EPS
  • HALO 4.37
  • TX 3.03
  • Revenue
  • HALO $1,178,672,000.00
  • TX $16,236,358,000.00
  • Revenue This Year
  • HALO $25.38
  • TX N/A
  • Revenue Next Year
  • HALO $20.19
  • TX $3.75
  • P/E Ratio
  • HALO $16.44
  • TX $10.66
  • Revenue Growth
  • HALO 34.97
  • TX N/A
  • 52 Week Low
  • HALO $42.01
  • TX $24.00
  • 52 Week High
  • HALO $72.33
  • TX $37.98
  • Technical
  • Relative Strength Index (RSI)
  • HALO 86.58
  • TX 59.57
  • Support Level
  • HALO $61.27
  • TX $31.64
  • Resistance Level
  • HALO $72.33
  • TX $33.15
  • Average True Range (ATR)
  • HALO 1.69
  • TX 0.80
  • MACD
  • HALO 0.77
  • TX 0.03
  • Stochastic Oscillator
  • HALO 96.06
  • TX 91.70

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.

Share on Social Networks: